Gut-Brain-Axis Therapeutics Inc. — Form D
Gut-Brain-Axis Therapeutics Inc. of TEMPE, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-06. The offering totals $20.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-11-06
- Form: D
- Accession: 0001996678-25-000002
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $20.0M
- Amount sold: $2.0M
- Remaining: $18.0M
- Investors: 22
- Date of first sale: 2025-10-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-563342
Issuer
- Name: Gut-Brain-Axis Therapeutics Inc.
- CIK: 0001996678
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1340 E VINEDO LANE, TEMPE, AZ, 85284
- Phone: (480) 818-0741
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Alexander B Khoruts | Director | Tempe, AZ |
| Rosa B Krajmalnik-Brown | Director | Tempe, AZ |
| Rosa J Krajalnik-Brown | Director | Tempe, AZ |
| Michael J Sadowsky | Director | Tempe, AZ |
| James B Adams | Director | Tempe, AZ |
| James B Adams | Executive Officer | Tempe, AZ |
| Alexander B Khorus | Director | Tempe, AZ |
Other filings by this issuer (1)
More